2 documents

Read All
07:00 , Aug 18, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Addex Pharmaceuticals SA Geneva, Switzerland Technology: Allosteric modulators Disease focus: Addiction Clinical status: Phase IIa Founded: May 2002 by Vincent Mutel, Mark Epping-Jordan, Tim Dyer, Jean-Philippe Rocher, and Robert Lutjens Corporate partners: NA University collaborators:...
Read More
07:00 , Jul 12, 2002 |  BC Extra  |  Financial News

Addex raises $10.5 million

Addex Pharmaceuticals (Geneva, Switzerland) raised $10.5 million in a private round. Investors included Index Ventures; Sofinnova Partners; TVM; BCV Initiative Capital; and individual investors. The company is developing compounds to treat addiction and neuropsychiatric conditions....
Read More